Title:
DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES
Document Type and Number:
WIPO Patent Application WO2003099771
Kind Code:
A3
Abstract:
The invention relates to the use of diaryl urea derivatives in the treatment of protein kinase dependent diseases or for the manufacture of pharmaceutical compositions for use in the treatment of said diseases, methods of use of diaryl urea derivatives in the treatment of said diseases, pharmaceutical preparations comprising diaryl urea derivatives for the treatment of said diseases, diaryl urea derivatives for use in the treatment of said diseases, novel diaryl urea derivatives, pharmaceutical preparations comprising these novel diaryl urea derivatives, processes for the manufacture of the novel diaryl urea derivatives, the use or methods of use of the novel diaryl urea derivatives as mentioned above, and/or these novel diaryl urea derivatives for use in the treatment of the animal or human body.
Inventors:
FLOERSHEIMER ANDREAS (CH)
FURET PASCAL (FR)
MANLEY PAUL WILLIAM (CH)
BOLD GUIDO (CH)
BOSS EUGEN (CH)
GUAGNANO VITO (CH)
VAUPEL ANDREA (CH)
FURET PASCAL (FR)
MANLEY PAUL WILLIAM (CH)
BOLD GUIDO (CH)
BOSS EUGEN (CH)
GUAGNANO VITO (CH)
VAUPEL ANDREA (CH)
Application Number:
PCT/EP2003/005634
Publication Date:
April 01, 2004
Filing Date:
May 28, 2003
Export Citation:
Assignee:
NOVARTIS AG (CH)
NOVARTIS PHARMA GMBH (AT)
FLOERSHEIMER ANDREAS (CH)
FURET PASCAL (FR)
MANLEY PAUL WILLIAM (CH)
BOLD GUIDO (CH)
BOSS EUGEN (CH)
GUAGNANO VITO (CH)
VAUPEL ANDREA (CH)
NOVARTIS PHARMA GMBH (AT)
FLOERSHEIMER ANDREAS (CH)
FURET PASCAL (FR)
MANLEY PAUL WILLIAM (CH)
BOLD GUIDO (CH)
BOSS EUGEN (CH)
GUAGNANO VITO (CH)
VAUPEL ANDREA (CH)
International Classes:
A61K31/33; A61K31/395; A61K31/4409; A61K31/4439; A61K31/4545; A61K31/4709; A61K31/496; A61K31/505; A61K31/506; A61K31/5377; A61P9/10; A61P11/06; A61P13/08; A61P15/08; A61P17/06; A61P19/02; A61P25/00; A61P25/02; A61P29/00; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P43/00; C07D213/36; C07D213/38; C07D213/40; C07D213/63; C07D213/64; C07D213/68; C07D213/69; C07D213/81; C07D213/84; C07D213/89; C07D239/30; C07D239/34; C07D239/42; C07D239/46; C07D239/47; C07D239/52; C07D401/04; C07D401/12; C07D403/12; (IPC1-7): C07D213/68; C07D213/40; C07D213/69; C07D239/34; C07D239/40; C07D239/26; C07D401/12; A61K31/33; A61P35/00; A61K31/395
Domestic Patent References:
| WO1999032463A1 | 1999-07-01 | |||
| WO2000042012A1 | 2000-07-20 | |||
| WO2001053274A1 | 2001-07-26 | |||
| WO1999000357A1 | 1999-01-07 | |||
| WO1993015043A1 | 1993-08-05 |
Other References:
B. R. BAKER ET AL.: "Irreversible enzyme inhibitors.", JOURNAL OF MEDICINAL CHEMISTRY., vol. 12, no. 1, 1969, AMERICAN CHEMICAL SOCIETY. WASHINGTON., US, pages 82 - 85, XP002253636, ISSN: 0022-2623
DATABASE CROSSFIRE BEILSTEIN BEILSTEIN INSTITUT ZUR FOERDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; XP002253637
DATABASE CROSSFIRE BEILSTEIN BEILSTEIN INSTITUT ZUR FOERDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; XP002253637
Download PDF:
Previous Patent: β-ALANINE DERIVATIVE AND USE THEREOF
Next Patent: CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES
Next Patent: CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES